BACKGROUND Interferon beta-la and -1b have been increasingly used for the treatment of multiple sclerosis (MS). The most frequent systemic adverse effects are flu-like symptoms. Laboratory abnormalities include asymptomatic leukopenia and elevated hepatic transaminases. Myelodysplastic Syndrome (MDS) refers to a spectrum of hematological disorders which can occur in different situations. Severa...

UNLABELLED This article is a review of different management strategies for the hematological manifestations of systemic lupus erythematosus (SLE), the strategies include immunosuppressive drugs, some noval therapies and B-cell depletion for refractory thrombocytopenia in patients with SLE and in antiphospholipid antibody syndrome associated with SLE. The researcher questions the validity of the...

Birth order was originally discovered in families with congenic malformations. Sewall Wright was one of the pioneers within this field around the time nineteen twenties. He was well aware of the fact that BOE is not in accordance with a traditional Mendelian segregation. He also described a relationship between parents age and BOE, in polydactyl for example with a maternal age effect, and outli...

Hematological disorders (HD) have been estimated to implicate approximately 1% of patients with arterial ischemic stroke. However, previously published studies are mostly retrospective or based on case reports or small series in selected young patients. We herein prospectively included consecutive patients with MRI-confirmed cerebral arterial infarctions among individuals admitted in our stroke...

Human red blood cells (RBCs) have remarkable deformability, squeezing through narrow capillaries as small as three microns in diameter without any damage. Several pathological conditions, including malaria, sickle cell disease (SCD), and diabetes can alter the shape and deformability of circulating RBCs. Recent work demonstrates how new computational and analytical models can reveal the ways in...

Allogeneic hematopoietic cell transplantation (HCT) has been successfully used as replacement therapy for patients with aplastic anemia and hemoglobinopathies. Both autologous and allogeneic HCT following high-dose chemotherapy can correct manifestations of autoimmune diseases. The impressive allogeneic graft-versus-tumor effects seen in patients given HCT for hematological malignancies have st...

although aplastic anemia (aa) and myelodysplastic syndrome (mds) are separate entities with different management, distinction between the two can be difficult on morphological basis due to hypocellularity of bone marrow. mds is one of the serious complications of aa. karyotyping is definitive in the diagnosis of mds. better and robust investigations like 18f-fluoro-deoxy-glucose positron emissi...

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) from a geno-identical matched sibling (MSD) is one of the most successful therapies in patients with non-malignant hematological disorders. This study included 273 patients with severe aplastic anemia (SAA), 152 patients with B-Thalassemia major (BTM), 31 patients with Fanconi's anemia (FA), 20 patients with congenital immunodeficie...

The comprehensive, basic and stimulating review article entitled “A novel approach to treatment in childhood acute myeloblastic leukemia and myelodysplastic syndrome with high-dose methylprednisolone as a differentiation and apoptosis–inducing agent of myeloid leukemia cells” by Prof. Hiçsönmez in the recent issue of the Journal gives me an opportunity to clarify this mode of treatment [1]. Alt...

CONTEXT Dysplastic changes are well documented in myelodysplastic syndromes (MDS). However, they are also observed in non-MDS hematological conditions. AIMS To evaluate the megakaryocytic alterations in the bone marrow aspirations in cases of non-MDS related thrombocytopenia. SETTING AND DESIGN A prospective study of 144 bone marrow aspirates was conducted in the department of pathology, Ka...